FdaApplication

ANDA 209309

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL RX SCIENCES LLC
application_typeANDA
approval_date2017-10-05

Products (3)

ProductActive ingredientStrengthDosage form
NADOLOLNADOLOL40MGTABLET;ORAL
NADOLOLNADOLOL20MGTABLET;ORAL
NADOLOLNADOLOL80MGTABLET;ORAL

3 products